Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in RPRX — Royalty Pharma plc

CIK 1109448 NASHVILLE, TN
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$59,549,816
+$2,095,284 QoQ
Shares Held
1,062,062
-11.3% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#57
of 646 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. RPRX ranks #23 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in RPRX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $59,549,816 1,062,062
2026-03-31 $57,454,532 1,197,718
2025-12-31 $39,442,475 1,020,768
2025-09-30 $33,052,350 936,858
2025-06-30 $32,421,307 899,842
2025-03-31 $38,633,917 1,241,051
2024-12-31 $29,443,080 1,154,178
2024-09-30 $36,211,765 1,280,020
2024-06-30 $34,567,800 1,310,876
2024-03-31 $43,869,950 1,444,516
2023-12-31 $38,466,417 1,369,399
2023-09-30 $5,938,747 218,819
2023-06-30 $6,830,520 222,203
2023-03-31 $10,502,961 291,506
2022-12-31 $6,326,243 160,077
2022-09-30 $13,109,086 326,259
2022-06-30 $16,271,960 387,059
2022-03-31 $12,572,353 322,699
2021-12-31 $6,239,314 156,570
2021-09-30 $5,778,027 159,879
2021-06-30 $6,509,580 158,809
2021-03-31 $4,060,454 93,087
2020-12-31 $2,511,108 50,172
2020-09-30 $1,712,753 40,712